Concepedia

Author

Angela Epp

Seagen (United States)

Also Known As

A. Epp, ANGELA EPP, Angela Epp, Epp, Angela

29

Publications

671

Citations

11

H-Index

33

Concepts

All Affiliations

Seagen (United States)Bloodworks NorthwestUniversity of WashingtonUniversity of FlorenceEKOS Corporation
AE

About

Angela Epp is an author at Seagen (United States) specializing in immunology, tumor immunity, and immunotherapy.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

3

3

68

2

Immunology

3

3

68

3

Cell Biology

2

2

22

4

Biomolecular Engineering

1

1

11

5

Clinical Immunology

1

1

11

Angela Epp

×

11

Publications

609

Citations

10

H-Index

YearCitations

KSHV-encoded CC chemokine vMIP-III is a CCR4 agonist, stimulates angiogenesis, and selectively chemoattracts TH2 cells

Johnny T. Stine, Christi L. Wood, Mark S. Hill,

Blood

2000

212

Macrophage-Derived Chemokine Is Localized to Thymic Medullary Epithelial Cells and Is a Chemoattractant for CD3+, CD4+, CD8low Thymocytes

David Chantry, Paola Romagnani, Carol J. Raport,

Blood

1999

102

CCR11 Is a Functional Receptor for the Monocyte Chemoattractant Protein Family of Chemokines

Vicki L. Schweickart, Angela Epp, Carol J. Raport,

Journal of Biological Chemistry

2000

95

Incomplete restoration of Mpl expression in the mpl−/− mouse produces partial correction of the stem cell–repopulating defect and paradoxical thrombocytosis

Brian J. Lannutti, Angela Epp, Jacqueline Roy,

Blood

2008

53

Abstract 2469: Brentuximab vedotin-mediated immunogenic cell death

Shyra J. Gardai, Angela Epp, Che‐Leung Law

Cancer Research

2015

46

SGN-B7H4V, an investigational vedotin ADC directed to the immune checkpoint ligand B7-H4, shows promising activity in preclinical models

Elizabeth Gray, Michelle Ulrich, Angela Epp,

Journal for ImmunoTherapy of Cancer

2023

33

Suppression of the Immune Response to FVIII in Hemophilia A Mice by Transgene Modified Tolerogenic Dendritic Cells

Rui-Jun Su, Angela Epp, Junli Feng,

Molecular Therapy

2011

19

Suppression of FVIII Inhibitor Formation in Hemophilic Mice by Delivery of Transgene Modified Apoptotic Fibroblasts

Rui-Jun Su, Angela Epp, Yvette Latchman,

Molecular Therapy

2009

17

A sugar engineered non-fucosylated anti-CD40 antibody, SEA-CD40, with enhanced immune stimulatory activity alone and in combination with immune checkpoint inhibitors.

Shyra J. Gardai, Angela Epp, Germein Linares,

Journal of Clinical Oncology

2015

11

Abstract 50: Targeting Sialyl-Thomsen nouveau (STn) antigen with the SGN-STNV antibody-drug conjugate is effective in preclinical studies

Alyssa D. Schwartz, Hector Rincon, Nanna Hansen,

Cancer Research

2021

11

Page 1